Overview
Intranasal Civamide for Episodic Cluster Headache
Status:
Completed
Completed
Trial end date:
2004-01-01
2004-01-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This is a 49-day study to evaluate the effectiveness of Intranasal Civamide (Zucapsaicin) in the treatment of an episodic cluster headache period compared to placebo (medically inactive substance which does not contain any active ingredients).Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Winston LaboratoriesTreatments:
Capsaicin
Pharmaceutical Solutions
Criteria
- At least 2 year history of episodic cluster headache (meeting IHS criteria)- At least 2 previous episodes
- Expected duration of cluster period is at least 6 weeks but not longer than 24 weeks
- At least 1 but not more than 8 headaches on each of the 3 days immediately prior to
treatment